These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20203643)

  • 21. Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question.
    Loria P; Lonardo A; Bellentani S; Day CP; Marchesini G; Carulli N
    Nutr Metab Cardiovasc Dis; 2007 Nov; 17(9):684-98. PubMed ID: 17560098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis.
    Miele L; Forgione A; Hernandez AP; Gabrieli ML; Vero V; Di Rocco P; Greco AV; Gasbarrini G; Gasbarrini A; Grieco A
    Eur Rev Med Pharmacol Sci; 2005; 9(5):273-7. PubMed ID: 16231589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.
    Malik SM; Devera ME; Fontes P; Shaikh O; Sasatomi E; Ahmad J
    Liver Transpl; 2009 Dec; 15(12):1843-51. PubMed ID: 19938117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Negative impact of de novo malignancies rather than alcohol relapse on survival after liver transplantation for alcoholic cirrhosis: a retrospective analysis of 305 patients in a single center.
    Dumortier J; Guillaud O; Adham M; Boucaud C; Delafosse B; Bouffard Y; Paliard P; Scoazec JY; Boillot O
    Am J Gastroenterol; 2007 May; 102(5):1032-41. PubMed ID: 17313502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noninvasive indices of fibrosis in NAFLD: starting to think about a three-hit (at least) phenomenon.
    Charlton M
    Am J Gastroenterol; 2007 Feb; 102(2):409-11. PubMed ID: 17311653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation.
    Yilmaz N; Shiffman ML; Stravitz RT; Sterling RK; Luketic VA; Sanyal AJ; Mills AS; Contos MJ; Coterell A; Maluf D; Posner MP; Fisher RA
    Liver Transpl; 2007 Jul; 13(7):975-83. PubMed ID: 17600360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures.
    Zelber-Sagi S; Nitzan-Kaluski D; Halpern Z; Oren R
    Liver Int; 2006 Sep; 26(7):856-63. PubMed ID: 16911469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations.
    Preiss D; Sattar N
    Clin Sci (Lond); 2008 Sep; 115(5):141-50. PubMed ID: 18662168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cirrhosis after orthotopic liver transplantation in the absence of primary disease recurrence.
    Seyam M; Neuberger JM; Gunson BK; Hübscher SG
    Liver Transpl; 2007 Jul; 13(7):966-74. PubMed ID: 17370332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-alcoholic fatty liver disease--a common and benign finding in octogenarian patients.
    Kagansky N; Levy S; Keter D; Rimon E; Taiba Z; Fridman Z; Berger D; Knobler H; Malnick S
    Liver Int; 2004 Dec; 24(6):588-94. PubMed ID: 15566509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-alcoholic fatty liver disease and hepatitis C infection.
    Bondini S; Younossi ZM
    Minerva Gastroenterol Dietol; 2006 Jun; 52(2):135-43. PubMed ID: 16557185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-transplant diabetes mellitus in liver transplantation: Hangzhou experience.
    Xu X; Ling Q; He ZL; Gao F; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):465-70. PubMed ID: 18842490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simple score for predicting alcohol relapse after liver transplantation: results from 387 patients over 15 years.
    De Gottardi A; Spahr L; Gelez P; Morard I; Mentha G; Guillaud O; Majno P; Morel P; Hadengue A; Paliard P; Scoazec JY; Boillot O; Giostra E; Dumortier J
    Arch Intern Med; 2007 Jun; 167(11):1183-8. PubMed ID: 17563028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatty liver and liver transplantation.
    Koehler E; Watt K; Charlton M
    Clin Liver Dis; 2009 Nov; 13(4):621-30. PubMed ID: 19818309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Non-alcoholic fatty liver disease in children: a new complication of obesity].
    Bocca G; Stolk RP; Scheenstra R; Sauer PJ
    Ned Tijdschr Geneeskd; 2008 Nov; 152(45):2443-7. PubMed ID: 19051794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histological assessment of non-alcoholic fatty liver disease.
    Hübscher SG
    Histopathology; 2006 Nov; 49(5):450-65. PubMed ID: 17064291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation.
    Ayata G; Gordon FD; Lewis WD; Pomfret E; Pomposelli JJ; Jenkins RL; Khettry U
    Hum Pathol; 2002 Nov; 33(11):1098-104. PubMed ID: 12454814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent concepts in non-alcoholic fatty liver disease.
    Adams LA; Angulo P
    Diabet Med; 2005 Sep; 22(9):1129-33. PubMed ID: 16108837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between non-alcoholic fatty liver disease and cardiovascular disease: a first message should pass.
    Picardi A; Vespasiani-Gentilucci U
    Am J Gastroenterol; 2008 Dec; 103(12):3036-8. PubMed ID: 18853984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States.
    Marrero JA; Fontana RJ; Su GL; Conjeevaram HS; Emick DM; Lok AS
    Hepatology; 2002 Dec; 36(6):1349-54. PubMed ID: 12447858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.